Executive record
Alpha ID: alpha:person:robert-cavorsiVersion: public-0As of: 2026-10-03
- Executive
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
Biography
Robert Cavorsi has served as Chief Business Officer since 2025, having previously served as Vice President of Strategy from 2021 to 2025, with over 20 years of experience at Organogenesis in roles spanning sales, marketing, national accounts, and business development. He holds a B.S. in Health Policy and Administration from The Pennsylvania State University.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Board service coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageExecutive career
- Current · dates not publishedVice President, Strategy · Organogenesis Holdings Inc.
- 2026 to end not publishedExecutive title: Vice President, Strategy · Organization not publishedORGO DEF 14A executive officers
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
ORGO DEF 14A executive officers
sec filing · Source published: Apr 30, 2026 · Retrieved: May 5, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
- Executive company: Executive at Organogenesis Holdings Inc. · Claim reviewed: May 5, 2026
- Executive title: Executive title: Vice President, Strategy · Claim reviewed: May 5, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026
Open source
sec def 14a · Source published: Apr 30, 2026 · Retrieved: Sep 12, 2026
Supports 1 claim
- Professional Role: Vice President, Strategy at Organogenesis Holdings Inc. · Claim reviewed: Sep 12, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03
- Biography
- published
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope